Celldex (NASDAQ: CLDX) reported Q1 EPS of ($0.56), $0.15 better than the analyst estimate of ($0.71). Revenue for the quarter came in at $156 thousand versus the consensus estimate of $732.6 thousand.

For earnings history and earnings-related data on Celldex (CLDX) click here.